BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

65.29

-0.32 (-0.49%)

At close: Aug 27, 2026, 4:00 PM EDT

64.00

-1.29 (-1.98%)

After-hours: Aug 27, 2026, 5:28 PM EDT

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	12,638	11,417	12,527	18,162	19,234	16,220
Market Cap Growth	12.51%	-8.86%	-31.03%	-5.57%	18.57%	1.90%
Enterprise Value	15,967	10,544	12,199	18,132	19,051	16,229
Last Close Price	65.61	59.43	65.73	96.42	103.49	88.35

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	172.28	32.72	29.35	108.34	135.87	-
Forward PE	10.73	12.37	17.86	38.98	39.00	85.79
PS Ratio	3.71	3.54	4.39	7.51	9.18	8.79
PB Ratio	2.01	1.88	2.21	3.67	4.18	3.80
P/TBV Ratio	16.06	2.05	2.44	4.10	4.73	4.41
P/FCF Ratio	17.12	15.75	25.70	290.28	350.06	77.63
P/OCF Ratio	14.74	13.79	21.87	114.04	109.34	53.26
PEG Ratio	0.37	0.65	0.72	1.07	0.86	2.66

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.69	3.27	4.28	7.50	9.09	8.79
EV/EBITDA Ratio	24.74	14.59	21.38	62.49	121.62	481.22
EV/EBIT Ratio	31.94	16.20	25.73	97.60	348.42	-
EV/FCF Ratio	21.62	14.54	25.03	289.80	346.74	77.67

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.67	0.11	0.11	0.23	0.24	0.26
Debt / EBITDA Ratio	6.41	0.88	1.08	3.73	6.58	23.56
Debt / FCF Ratio	5.69	0.89	1.30	18.12	20.38	5.38
Net Debt / Equity Ratio	0.53	-0.15	-0.09	0.01	-0.04	0.03
Net Debt / EBITDA Ratio	5.16	-1.27	-0.88	0.21	-1.10	3.25
Net Debt / FCF Ratio	4.51	-1.27	-1.03	0.96	-3.12	0.52
Asset Turnover	0.36	0.44	0.41	0.37	0.34	0.31
Inventory Turnover	1.07	1.20	1.14	1.28	1.38	1.49
Quick Ratio	1.16	3.25	2.96	1.45	2.98	2.54
Current Ratio	2.39	5.21	5.33	2.51	4.67	4.16
Return on Equity (ROE)	1.18%	5.94%	8.05%	3.51%	3.19%	-1.53%
Return on Assets (ROA)	3.26%	5.58%	4.29%	1.76%	0.55%	-0.78%
Return on Invested Capital (ROIC)	3.24%	9.12%	7.35%	3.50%	1.18%	-1.74%
Return on Capital Employed (ROCE)	5.00%	9.50%	7.40%	3.30%	0.90%	-1.40%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	0.58%	3.06%	3.41%	0.92%	0.74%	-0.40%
FCF Yield	5.84%	6.35%	3.89%	0.34%	0.29%	1.29%
Buyback Yield / Dilution	-0.61%	-0.35%	-2.67%	-1.39%	-3.34%	4.61%

SEC Filings: 10-K · 10-Q